Clinical Trial Detail

NCT ID NCT02840994
Title A Trial of CV301 in Combination With Nivolumab Versus Nivolumab in Subjects With Previously Treated Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bavarian Nordic, Inc.

lung non-small cell carcinoma

Advanced Solid Tumor


CV301 + Nivolumab


Age Groups: adult senior

No variant requirements are available.